Combinatorial latency reactivation for HIV-1 subtypes and variants - Wikidata - wikimedia - TriplyDB

Combinatorial latency reactivation for HIV-1 subtypes and variants

Combinatorial latency reactivation for HIV-1 subtypes and variants

http://www.wikidata.org/entity/Q33877492

about

Impact of Chromatin on HIV Replication HIV-1 functional cure: will the dream come true?Recent developments in human immunodeficiency virus-1 latency research Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.Eradication therapies for HIV Infection: time to begin again.Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells.A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB Finding a cure for HIV: will it ever be achievable?Interaction between endogenous bacterial flora and latent HIV infection.Histone deacetylase inhibitors and HIV latency.Calcium/calcineurin synergizes with prostratin to promote NF-κB dependent activation of latent HIV COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization Promoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.Reactivation of latent HIV-1 by new semi-synthetic ingenol esters.Sulfonation pathway inhibitors block reactivation of latent HIV-1.Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy.Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.Quantitative evaluation and optimization of co-drugging to improve anti-HIV latency therapy Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.Chromatin accessibility at the HIV LTR promoter sets a threshold for NF-κB mediated viral gene expression The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention.A passive-flow microfluidic device for imaging latent HIV activation dynamics in single T cells BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication Distinct promoter activation mechanisms modulate noise-driven HIV gene expression.NF-κB/Rel: agonist and antagonist roles in HIV-1 latency.Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral Therapy.Targeting HIV latency: pharmacologic strategies toward eradication.HIV-1 transcription and latency: an update.Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.Altering cell death pathways as an approach to cure HIV infection.High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development

P2860

Q26782046-0F175019-8D8F-45FE-AB9B-42D5F5C1113A Q26865803-44D2E06A-73D0-4001-AEF0-2FAEB55D0020 Q27013114-11DD437D-716E-45F8-BE79-5C6279D3399A Q27026631-53A32F75-6673-4157-A808-BA2D9445A713 Q28537694-2FF8F049-159D-4C62-A4BF-5CFB5B28E471 Q30399588-28A65B43-BFC5-4F7F-8229-2DF24B15750C Q33613493-10E3EBF7-255E-44AC-BF70-9853373EE1FC Q33838633-09D066DF-0D24-41F6-AD58-C4B1CAD3A674 Q34145909-F6E7E64E-3358-4F91-A395-F7CEDD9EA324 Q34482017-A203277E-06CD-487C-BECA-60CF50E9DA9D Q34567084-0F605505-E252-4E07-8B09-0596D63D3EA2 Q34686713-E135143A-0B23-4C7A-943E-79B0B65B640C Q34816844-D6351E2D-180A-4C5B-8447-5611ACB8007C Q35035572-C0C6A4A6-16D2-4891-92BF-C8B26536AED7 Q35076655-77C61950-8B86-49E7-9B47-3D4D3AB902B0 Q35133922-425BFD39-5216-4A8D-B857-56C85CB383EB Q35252186-B4186343-5B5D-4AD0-9B55-6143D5CAF26E Q35252396-4BADD46E-8346-455C-A47B-BCEC262D5CC7 Q35358497-97EACE17-F511-4005-A68D-72E16BAB68E0 Q35436367-B58980B0-18B5-4ACE-8D52-581D965BC67A Q35549754-1E523562-7352-4BE4-941F-8A06599C3B35 Q35720063-C3FFE0BE-BB36-446D-A32B-BE7573AF7C8B Q35848096-ABE930AF-4CFF-4659-90C7-8B37C2E53BAB Q35942658-EF00F8F8-C7CA-4FA0-BD88-CAC04BD10CB2 Q35996134-82C0D92E-AE01-4B90-8899-20939B908AFD Q36001865-C58964E3-F052-4B03-8BEC-A94CDDB497A4 Q36021924-C5886878-55A1-450F-9880-093971409D66 Q36198250-2E203E77-4CD2-413E-9939-998EB08AE597 Q36206925-57EF0CEF-2D16-4DC5-A2DF-85F07A8F43E4 Q36330062-3701CED3-C48F-4AEC-8D0B-8D64383948EA Q36369858-D366CB31-3418-4257-8110-287BDADAE308 Q36383606-9C4FA1C8-37DA-434A-81AB-FFED8CD69C96 Q36538827-13CD3410-E029-4FCE-90E1-8DA8A5B4D733 Q36644877-F77B6D80-8180-4E7A-8EB0-1FC3D09147F7 Q36901950-39B01B08-44C8-4E5D-A05C-2F5B4BE19C61 Q36976156-EB0ABFD9-C4C7-467F-A08B-AF943C768E70 Q37041173-20EF1FF0-7CFA-4F92-BD16-D001AD17AFAE Q37062057-14974180-277C-4341-8E0D-B5E73C7BAC95 Q37123276-1E1A77C0-ADA1-4CFD-8796-3648EFE458F9 Q37127522-943DBF4F-3E15-44D7-BA69-80E6A79E309B

P2860

Combinatorial latency reactivation for HIV-1 subtypes and variants

http://www.wikidata.org/entity/Q33877492

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Combinatorial latency reactivation for HIV-1 subtypes and variants

@ast

Combinatorial latency reactivation for HIV-1 subtypes and variants

@en

type

label

Combinatorial latency reactivation for HIV-1 subtypes and variants

@ast

Combinatorial latency reactivation for HIV-1 subtypes and variants

@en

prefLabel

Combinatorial latency reactivation for HIV-1 subtypes and variants

@ast

Combinatorial latency reactivation for HIV-1 subtypes and variants

@en

P1433

Q33877492-05497857-D0BE-4137-AFEA-E5C6B926B161

P1476

Q33877492-05A21296-84BD-49BF-9D91-829AFDCE8F61

P2093

Q33877492-552996CB-D9BA-4730-9E96-9D132641696A

Q33877492-805EE0FB-37CE-4493-B244-2A3845D36F92

Q33877492-98B1A177-5F1C-42E3-936D-ADE804657141

Q33877492-C5B123DB-E3CC-44ED-9B3B-B2EB83601B62

Q33877492-E8525A58-7F76-47D3-9EB0-CE2A83F2D5C2

P2860

Q33877492-03DCC666-CCC9-42C0-BB98-723161C38697

Q33877492-0C7B72D8-3802-4DAF-8923-6C1F80EB3455

Q33877492-0DEC2C52-1642-4A7B-B87F-28553E93CB9C

Q33877492-0E6915E3-FDAF-4566-8C8F-A97ADC8924B0

Q33877492-0F348347-E911-4C2F-8BF5-BB536BF172A2

Q33877492-11299340-950D-4BFE-BB62-98EA15DF11A7

Q33877492-1158EE06-88B1-48DC-AE4D-A81BE106A55C

Q33877492-161ED5E2-FA7E-4605-BEF5-2FCFADC64171

Q33877492-16B5C447-D5F1-4777-8FBB-18857991BB9A

Q33877492-1781A18C-696D-4FED-ACD7-117D4A9DEE01

P304

Q33877492-4AC6C93F-9A16-4B95-BCE4-CC6B126067F7

P31

Q33877492-14AE4AA1-D8FF-48D1-8DF5-6FB69B348AE4

P356

Q33877492-4897B22E-8D54-4EFC-B738-7410001F99DD

P433

Q33877492-5D7B9715-E4AC-41FA-A4F5-847B72ABF702

P478

Q33877492-5E432895-79BE-460D-ABB0-4976B156B8F4

P50

Q33877492-10C66B7E-B357-4548-9CBE-6FC10ED85AE6

P577

Q33877492-1DA66073-8FD0-417B-94F0-E72DAC098959

P698

Q33877492-6ECD0C61-A62B-4BF9-B296-755001BE4A7E

P932

Q33877492-9B854C3A-F0F3-42C1-BD8D-42DD74AFCAED

P356

P1433

Journal of Virology

P1476

Combinatorial latency reactivation for HIV-1 subtypes and variants

@en

P2093

Adam P Arkin

http://www.w3.org/2001/XMLSchema#string

Arash Calafi

http://www.w3.org/2001/XMLSchema#string

David V Schaffer

http://www.w3.org/2001/XMLSchema#string

John J Rossi

http://www.w3.org/2001/XMLSchema#string

Kwang-Il Lim

http://www.w3.org/2001/XMLSchema#string

P2860

The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes

Cloning of a cellular factor, interleukin binding factor, that binds to NFAT-like motifs in the human immunodeficiency virus long terminal repeat

The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.

Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat

Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue

Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter

Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells

Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat

P304

5958-5974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00161-10

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

John C. Burnett

P577

2010-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20357084

http://www.w3.org/2001/XMLSchema#string

P932

2876650

http://www.w3.org/2001/XMLSchema#string